• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“让孕妇为自己和孩子选择命运”。西班牙生育诊所数字平台如何构建植入前基因检测(PGT)

Let 'Pregnant Women Choose the Destiny for Themselves and Their Child'. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain.

作者信息

Turrini Mauro, Otín-Gavín Jorge

机构信息

Instituto de Políticas y Bienes Públicos (IPP), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Independent Researcher.

出版信息

Sociol Health Illn. 2025 Jan;47(1):e13876. doi: 10.1111/1467-9566.13876.

DOI:10.1111/1467-9566.13876
PMID:39785671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11715153/
Abstract

Preimplantation Genetic Testing (PGT) is used to select in vitro embryos for distinct clinical contexts and purposes. PGT for monogenic conditions (PGT-M), also known as Preimplantation Genetic Diagnosis (PGD), enables the prevention of passing on a known genetic disorder to one's offspring. Conversely, PGT for aneuploidies (PGT-A), or Preimplantation Genetic Screening (PGS), is used to improve IVF success rates in fertility patients and increase confidence about the health outcomes of potential offspring. Using discourse analysis, we examine how Spanish fertility clinic digital platforms frame these techniques and their associated subjectivity processes. We find: first, an excessively unproblematic portrayal of experimental innovations such as PGT; second, a linguistic, semantic and clinical overlap between 'diagnosis' and 'screening', which increases the genetic responsibility of couples or women without known genetic conditions regarding their prospective children; and third, the use of genomics as a modulator of female fertility and as a means to control maternal age-related decline. Ultimately, this discourse positions PGT as a routine IVF component, serving as an assurance tool for both treatment success and the health of the potential baby. This narrative reflects the speculative turn in assisted reproduction, emphasising new forms of responsibility and choice of would-be mothers.

摘要

植入前基因检测(PGT)用于在不同临床背景和目的下选择体外胚胎。单基因疾病的植入前基因检测(PGT-M),也称为植入前基因诊断(PGD),能够防止将已知的遗传疾病传给后代。相反,非整倍体的植入前基因检测(PGT-A),即植入前基因筛查(PGS),用于提高生育患者体外受精的成功率,并增强对潜在后代健康状况的信心。通过话语分析,我们研究了西班牙生育诊所数字平台如何构建这些技术及其相关的主体性过程。我们发现:第一,对PGT等实验性创新的描述过于毫无问题;第二,“诊断”和“筛查”之间存在语言、语义和临床重叠,这增加了没有已知遗传疾病的夫妇或女性对其未来子女的遗传责任;第三,将基因组学用作女性生育能力的调节因素以及控制与母亲年龄相关的生育能力下降的手段。最终,这种话语将PGT定位为体外受精的常规组成部分,作为治疗成功和潜在婴儿健康的保证工具。这种叙述反映了辅助生殖中的投机转向,强调了未来母亲的新形式责任和选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/fa3e702dd66a/SHIL-47-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/5531fad7616f/SHIL-47-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/6329319e9c89/SHIL-47-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/fa3e702dd66a/SHIL-47-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/5531fad7616f/SHIL-47-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/6329319e9c89/SHIL-47-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9012/11715153/fa3e702dd66a/SHIL-47-0-g002.jpg

相似文献

1
Let 'Pregnant Women Choose the Destiny for Themselves and Their Child'. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain.“让孕妇为自己和孩子选择命运”。西班牙生育诊所数字平台如何构建植入前基因检测(PGT)
Sociol Health Illn. 2025 Jan;47(1):e13876. doi: 10.1111/1467-9566.13876.
2
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.体外受精中对非整倍体(染色体数量异常)进行植入前基因检测。
Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3.
3
Preimplantation genetic testing for more than one genetic condition: clinical and ethical considerations and dilemmas.针对多种遗传疾病的胚胎植入前遗传学检测:临床与伦理考量及困境。
Hum Reprod. 2019 Jun 4;34(6):1146-1154. doi: 10.1093/humrep/dez059.
4
Implicit bias in diagnosing mosaicism amongst preimplantation genetic testing providers: results from a multicenter study of 36 395 blastocysts.胚胎植入前遗传学检测提供者在诊断嵌合体时的内隐偏倚:一项 36395 个囊胚的多中心研究结果。
Hum Reprod. 2024 Jan 5;39(1):258-274. doi: 10.1093/humrep/dead213.
5
IVF outcomes of embryos with abnormal PGT-A biopsy previously refused transfer: a prospective cohort study.PGT-A 活检异常的胚胎 IVF 结局:一项前瞻性队列研究。
Hum Reprod. 2022 May 30;37(6):1194-1206. doi: 10.1093/humrep/deac063.
6
Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).最大限度地减少嵌合体:评估胚胎植入前遗传学检测(PGT-A)中下一代测序(NGS)后不同受精方法对嵌合体发生率的影响。
J Assist Reprod Genet. 2019 Jan;36(1):153-157. doi: 10.1007/s10815-018-1347-6. Epub 2018 Oct 25.
7
An overview of the current and emerging platforms for preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilization programs.体外受精项目中胚胎植入前遗传学检测非整倍体(PGT-A)的现有和新兴平台概述。
Taiwan J Obstet Gynecol. 2020 Jul;59(4):489-495. doi: 10.1016/j.tjog.2020.05.004.
8
Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.体外受精和胚胎植入前遗传学检测预防 BRCA1/2 突变传递的成本效益。
Hum Reprod. 2020 Feb 29;35(2):434-445. doi: 10.1093/humrep/dez203.
9
Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.体外受精和一般人群中管理生殖遗传风险的孕前扩展携带者筛查的临床有效性和实用性。
Hum Reprod. 2021 Jun 18;36(7):2050-2061. doi: 10.1093/humrep/deab087.
10
Preimplantation genetic testing in the current era, a review.当前时代的植入前基因检测,一篇综述。
Arch Gynecol Obstet. 2024 May;309(5):1787-1799. doi: 10.1007/s00404-024-07370-z. Epub 2024 Feb 20.

本文引用的文献

1
Patient informed choice in the age of evidence-based medicine: IVF patients' approaches to biomedical evidence and fertility treatment add-ons.在循证医学时代的患者知情选择:IVF 患者对生物医学证据和生育治疗附加手段的态度。
Sociol Health Illn. 2023 Feb;45(2):225-241. doi: 10.1111/1467-9566.13581. Epub 2022 Nov 11.
2
ART in Europe, 2018: results generated from European registries by ESHRE.2018年欧洲辅助生殖技术:欧洲人类生殖与胚胎学会(ESHRE)基于欧洲登记处得出的结果
Hum Reprod Open. 2022 Jul 5;2022(3):hoac022. doi: 10.1093/hropen/hoac022. eCollection 2022.
3
From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain.
从稀缺到姐妹情谊:英国、比利时和西班牙生育诊所网站上卵子捐赠的框架构建
Soc Sci Med. 2022 Mar;296:114785. doi: 10.1016/j.socscimed.2022.114785. Epub 2022 Feb 8.
4
Enacting evidence-based medicine in fertility care: Tensions between commercialisation and knowledge standardisation.在生育保健中实施循证医学:商业化与知识标准化之间的紧张关系。
Sociol Health Illn. 2021 Nov;43(9):2015-2030. doi: 10.1111/1467-9566.13381. Epub 2021 Sep 26.
5
Assisted reproduction in Spain, outcome and socioeconomic determinants of access.西班牙的辅助生殖技术、结局及获得途径的社会经济学决定因素。
Int J Equity Health. 2021 Jul 6;20(1):156. doi: 10.1186/s12939-021-01438-x.
6
Preimplantation Genetic Testing for Aneuploidy - a Castle Built on Sand.胚胎植入前遗传学检测 - 沙上之塔。
Trends Mol Med. 2021 Aug;27(8):731-742. doi: 10.1016/j.molmed.2020.11.009. Epub 2021 Jan 11.
7
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.体外受精中对非整倍体(染色体数量异常)进行植入前基因检测。
Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3.
8
The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.生育诊所网站上三种试管婴儿附加服务的流行程度、推广情况和定价。
Reprod Biomed Online. 2020 Nov;41(5):801-806. doi: 10.1016/j.rbmo.2020.07.021. Epub 2020 Jul 27.
9
The International Glossary on Infertility and Fertility Care, 2017.《国际不孕不育和生育保健词汇表》,2017 年。
Hum Reprod. 2017 Sep 1;32(9):1786-1801. doi: 10.1093/humrep/dex234.
10
Preimplantation genetic screening.植入前基因筛查
J Med Screen. 2018 Mar;25(1):1-5. doi: 10.1177/0969141317691797. Epub 2017 Jun 14.